What is ENOUGH?
Founded in 2015, ENOUGH—formerly known as 3F BIO—operates at the intersection of biotechnology and sustainable food systems. The company specializes in the production of mycoprotein, a high-quality, plant-based protein source that effectively mimics the texture and nutritional profile of animal-derived products. By harnessing the inherent efficiency of natural fermentation, ENOUGH addresses the growing global demand for sustainable, low-carbon food alternatives. Its market position is defined by a commitment to reducing the environmental footprint of the food industry, providing a scalable solution that aligns with international climate goals and the increasing consumer preference for ethical, resource-efficient nutrition.
How much funding has ENOUGH raised?
ENOUGH has raised a total of $43.5M across 1 funding round:
Other Financing Round
$43.5M
Other Financing Round (2023): $43.5M with participation from World Fund, CPT Capital, and HAL Investments
Key Investors in ENOUGH
World Fund
World Fund is a leading European venture capital fund that invests in entrepreneurs developing climate technology capable of reducing at least 100 million tons of CO2e emissions annually.
CPT Capital
CPT Capital is an investment firm focused on the future of food and materials, specifically in the alternative protein sector, partnering with founders who utilize cutting-edge technologies to replace animals in the supply chain.
HAL Investments
HAL Investments is the Dutch investment subsidiary of HAL Holding N.V., focusing on acquiring significant shareholdings in various companies to enhance long-term shareholder value.
What's next for ENOUGH?
With this major enterprise-level funding, ENOUGH is poised to scale its operations significantly, moving from pilot-scale success to industrial-level output. The strategic focus will likely center on expanding manufacturing infrastructure to meet the rising demand from food manufacturers seeking sustainable ingredients. Furthermore, the company is expected to deepen its research and development efforts to optimize production yields and explore new applications for its fungal-based protein. By maintaining its focus on decarbonization and resource efficiency, ENOUGH is well-positioned to lead the next wave of innovation in the alternative protein sector, potentially disrupting traditional animal agriculture on a global scale.
See full ENOUGH company page
